Effect of a Mixture of Allium Extracts on LDL Cholesterol Levels Volunteers With Elevated LDL Cholesterol Levels
Evaluation of the Effect of Consuming a Mixture of Concentrated Allium Extracts on LDL Cholesterol Levels in Healthy Volunteers With Elevated LDL Cholesterol Levels
1 other identifier
interventional
64
1 country
1
Brief Summary
To evaluate the efficacy of daily consumption of a combination of concentrated extracts of garlic (Allium sativum L.) and onion (Allium cepa L.) on LDL cholesterol levels in healthy volunteers. Parameters related to metabolic syndrome, cardiovascular health and the immune system will also be analyzed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 22, 2020
CompletedFirst Posted
Study publicly available on registry
November 30, 2020
CompletedStudy Start
First participant enrolled
February 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 29, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2022
CompletedFebruary 23, 2023
November 1, 2021
1.9 years
October 22, 2020
February 22, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
LDL
Serum LDL cholesterol
8 weeks.
Study Arms (2)
Control
PLACEBO COMPARATORMicrocrystalline cellulose (9892- Capsules®) up to 400 mg.
Intervention
EXPERIMENTALGarlic concentrated extract. Onion concentrated extract. Microcrystalline cellulose (9892- Capsules®) up to 400 mg.
Interventions
Garlic extract concentrate (equivalent to 2 garlic cloves) and onion extract concentrate (equivalent to 1 onion).
Eligibility Criteria
You may qualify if:
- LDL-cholesterol levels between 100 and 190 mg/dL.
- Freely agree to participate in the study and sign the informed consent document.
You may not qualify if:
- Be pregnant.
- Have planned to change lifestyle and / or dietary habits.
- Having diabetes.
- Having a cerebrovascular disease.
- Having a serious illness.
- Taking products or drugs to control cholesterol levels or with antioxidant activity.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- DOMCA S.A.lead
Study Sites (1)
Domca Sau
Alhendín, Granada, 18620, Spain
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Miguel Quesada, MD
Endocrinology and Nutrition Clinic of Dr. Miguel Quesada
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Each volunteer is assigned a "participant number" that will be associated with a pot that will have all the product for the study. The "pot number" is the same as the "participant number".
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 22, 2020
First Posted
November 30, 2020
Study Start
February 1, 2021
Primary Completion
December 29, 2022
Study Completion
December 30, 2022
Last Updated
February 23, 2023
Record last verified: 2021-11